建信中证创新药产业ETF(159835)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
4,955,750.59 |
16,518,674.09 |
-15,984,914.29 |
-24,418,930.68 |
| 利息合计 |
36,173.39 |
15,989.64 |
42,345.87 |
18,559.12 |
| 其中：存款利息收入 |
36,173.39 |
15,989.64 |
42,345.87 |
18,559.12 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
693,943.05 |
-2,419,522.62 |
-15,128,766.93 |
-10,320,869.11 |
| 其中：股票投资收益 |
-951,000.82 |
-3,397,386.53 |
-16,416,668.20 |
-11,041,312.76 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
1,644,943.87 |
977,863.91 |
1,287,901.27 |
720,443.65 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
4,314,570.81 |
18,989,945.03 |
-1,142,980.67 |
-14,209,132.46 |
| 其他收入 |
-88,936.66 |
-67,737.96 |
244,487.44 |
92,511.77 |
| 费用 |
1,276,967.40 |
510,546.28 |
818,733.51 |
392,749.31 |
| 管理人报酬 |
807,472.85 |
298,176.01 |
458,944.57 |
207,118.00 |
| 基金托管费 |
161,494.55 |
59,635.23 |
91,788.94 |
41,423.61 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
308,000.00 |
152,735.04 |
268,000.00 |
144,207.70 |
| 利润总额 |
3,678,783.19 |
16,008,127.81 |
-16,803,647.80 |
-24,811,679.99 |
微信公众号
证券之星APP
基本资料
